4153 Stock Overview
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
DIVA Laboratories, Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$39.05 |
52 Week High | NT$49.55 |
52 Week Low | NT$31.00 |
Beta | 0.23 |
1 Month Change | -0.51% |
3 Month Change | 8.62% |
1 Year Change | -14.18% |
3 Year Change | 69.05% |
5 Year Change | -12.07% |
Change since IPO | 136.97% |
Recent News & Updates
Shareholder Returns
4153 | TW Electronic | TW Market | |
---|---|---|---|
7D | 2.6% | -0.7% | -1.6% |
1Y | -14.2% | 24.5% | 25.9% |
Return vs Industry: 4153 underperformed the TW Electronic industry which returned 24.5% over the past year.
Return vs Market: 4153 underperformed the TW Market which returned 25.9% over the past year.
Price Volatility
4153 volatility | |
---|---|
4153 Average Weekly Movement | 3.1% |
Electronic Industry Average Movement | 5.2% |
Market Average Movement | 4.6% |
10% most volatile stocks in TW Market | 8.6% |
10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4153 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4153's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | n/a | Guo-Sen Chen | www.diva.com.tw |
DIVA Laboratories, Ltd. manufactures and sells display solutions worldwide. The company provides endo/surgical displays, which provide static and dynamic images for hybrid and integrated ORs, and control room applications; color and mono displays for radiology and medical imaging; touch displays/human machine interface products; medical and industrial cases; and displays to ODM and OEM customers. It also offers video solutions.
DIVA Laboratories, Ltd. Fundamentals Summary
4153 fundamental statistics | |
---|---|
Market cap | NT$2.29b |
Earnings (TTM) | NT$73.62m |
Revenue (TTM) | NT$893.84m |
31.1x
P/E Ratio2.6x
P/S RatioIs 4153 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4153 income statement (TTM) | |
---|---|
Revenue | NT$893.84m |
Cost of Revenue | NT$643.07m |
Gross Profit | NT$250.77m |
Other Expenses | NT$177.16m |
Earnings | NT$73.62m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
Earnings per share (EPS) | 1.25 |
Gross Margin | 28.06% |
Net Profit Margin | 8.24% |
Debt/Equity Ratio | 0% |
How did 4153 perform over the long term?
See historical performance and comparison